SOD1 and amyotrophic lateral sclerosis: As the authors stated, the small sample size reflected the rarity of the SOD1-ALS population: estimated at 320 patients across the whole USA, not all of whom would have consented, and recruitment was in competition with two other clinical trials at the time.